Cargando…
Application of graft-derived cell-free DNA in ornithine transcarbamylase deficiency patient after living donor liver transplantation: Two case reports
RATIONALE: Graft-derived-cell-free DNA (Gcf-DNA) in plasma was a promising biomarker to monitor graft-rejection after liver transplantation. However, little is known about the application of Gcf-DNA in living-donor-liver-transplantation (LDLT). PATIENTS CONCERN: In this study, 2 patients diagnosed w...
Autores principales: | Ng, Hoi-Ioi, Sun, Li-Ying, Zhu, Zhi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320025/ https://www.ncbi.nlm.nih.gov/pubmed/30572553 http://dx.doi.org/10.1097/MD.0000000000013843 |
Ejemplares similares
-
Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014) -
Liver transplantation for late-onset ornithine transcarbamylase deficiency: A case report
por: Fu, Xiao-Hui, et al.
Publicado: (2022) -
Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort study
por: Seker Yilmaz, Berna, et al.
Publicado: (2023) -
Gene Mutation Analysis and Prenatal Diagnosis of the Ornithine Transcarbamylase (OTC) Gene in Two Families with Ornithine Transcarbamylase Deficiency
por: Li, Sitao, et al.
Publicado: (2018) -
Ornithine transcarbamylase deficiency: A diagnostic odyssey
por: Knerr, Ina, et al.
Publicado: (2022)